STADE‐HF (sST2 As a help for management of HF): a pilot study

AIMS: Biomarkers are not recommended until now to guide the management of patients with heart failure (HF). Soluble suppression of tumorigenicity 2 (sST2) appears as a promising biomarker. The current study considered pre‐discharged sST2 values as a guide for medical management in patients admitted...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:ESC Heart Fail
Glavni autori: Huet, Fabien, Nicoleau, Jean, Dupuy, Anne‐Marie, Curinier, Corentin, Breuker, Cyril, Castet‐Nicolas, Audrey, Lotierzo, Manuela, Kalmanovich, Eran, Zerkowski, Laetitia, Akodad, Mariama, Adda, Jérôme, Agullo, Audrey, Leclercq, Florence, Pasquie, Jean‐Luc, Battistella, Pascal, Roubille, Camille, Fesler, Pierre, Mercier, Grégoire, Bourel, Guillaume, Cristol, Jean‐Paul, Roubille, François
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Short Communications
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160465/
https://ncbi.nlm.nih.gov/pubmed/32168423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12663
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items